US OptionsDetailed Quotes

AXGN241220C7500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 29 09:30 ET

0.00High0.00Low

AxoGen Stock Discussion

Jsmooth420365

Sep 6 07:55

$AxoGen (AXGN.US)$ like it over 13.50

Cantor Fitzgerald sees AVITA's superior growth and high gross margins as reasons for a premium. The firm also sees potential in Pacific Biosciences and AxoGen, and expects positive share price appreciation for Exagen and NeuroPace. A significant catalyst for Nyxoah's stock is anticipated with upcoming DREAM study data.

Cantor Picks RCEL as Best 2024 Medtech Idea; Bullish on PACB, AXGN, CERS

Moomoo AI

Jan 7 09:21

AxoGen's EBIT loss and debt levels could strain its balance sheet despite its US$368.0m market cap. While revenue is growing, its financial performance is considered slow.

Does AxoGen (NASDAQ:AXGN) Have A Healthy Balance Sheet?

Moomoo AI

Dec 26, 2023 19:36

CEO of Axogen, Karen Zaderej is excited for Kathy Weiler to use her vast commercial knowledge to aid the company's goal of becoming cash flow positive. Weiler herself is equally fired up to be able to aid in Axogen's commercial success.

Press Release: Axogen, Inc. Appoints Kathy Weiler to Its Board of Directors

Moomoo AI

Dec 15, 2023 04:44

The recent insider selling, despite small insider buying in AxoGen, raises concerns on the stock. Despite the reasonably high level of insider ownership, the history of sales makes the investment prospect less attractive in the immediate term.

Don't Ignore The Insider Selling In AxoGen

Bigmoney Dreamer

Nov 8, 2023 01:03

$AxoGen (AXGN.US)$
looks like more 💰flow and narrower loss this years looks interesting here

Bigmoney Dreamer

Nov 8, 2023 00:56

$AxoGen (AXGN.US)$ one more day will determine bigger picture still watching

Moomoo Breakfast US

Jul 19, 2022 07:33

Columns Today's pre-market stock movers: NFLX, IBM, LMT, SI and more

Gainers:
In reaction to earnings/guidance:
• $Silvergate Capital (SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen (AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $Novartis AG (NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...

Moomoo Breakfast US

May 5, 2022 07:27

Columns Today's pre-market stock movers: BKNG, TWTR, SHOP, EBAY and more

Gainers:
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...

No comment yet